Recent Research Shows Significant Benefits In Acute Ischaemic Stroke With Actilyse(R) Beyond Currently Approved Three Hour Treatment Window
September 25th, 2008 by 
admin First results from ECASS 3 (European Cooperative Acute Stroke Study) were presented today at the 6th World Stroke legislature in Vienna, Austria, display that communication with Actilyse® (alteplase) between 3 and 4.5 hours after attack start crapper meliorate clinical outcome. These results were also publicised today in the New England Journal of Medicine.
Posted in Cardiology | 